Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
119,358,581
-
Total 13F shares
-
137,672,960
-
Share change
-
+2,706,529
-
Total reported value
-
$4,548,776,123
-
Put/Call ratio
-
31%
-
Price per share
-
$33.04
-
Number of holders
-
308
-
Value change
-
+$22,757,186
-
Number of buys
-
167
-
Number of sells
-
175
Institutional Holders of CYTOKINETICS INC - COMMON STOCK (CYTK) as of Q2 2025
As of 30 Jun 2025 CYTOKINETICS INC - COMMON STOCK (CYTK) had 308 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 137,672,960 shares of stock of the company.
Largest 10 holders included T. Rowe Price Investment Management, Inc., BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, Deep Track Capital, LP, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, and Vestal Point Capital, LP.
This table shows 308 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.